The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
632719
WO Application Number:
US9302808
Type:
European Patent Granted for NL
Status:
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Non-payment of the annual fee
Application number:
939085858
WO Publication Number:
WO9319738
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
EP632719;
Dates
Filing date:
24/03/1993
Grant date:
11/09/1996
EP Publication Date:
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
11/09/1996
EP B1 Publication Date:
11/09/1996
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
01/11/1996
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
23/03/2013
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
01/10/2009
Applicant/holder
From:
11/09/1996
Name:
SEQUUS PHARMACEUTICALS, INC.
Address:
Menlo Park, CA 94025, United States of America (US)
Domicile Holder
1
Name:
Drs. M.J. Hatzmann c.s.
From:
13/07/2005
Address:
Vereenigde, Postbus 87930, 2508 DH Den Haag, Netherlands (NL)
To:
2
Name:
Drs. M.J. Hatzmann c.s.
From:
15/05/1996
Address:
Vereenigde, Postbus 87930, 2508 DH Den Haag, Netherlands (NL)